Insights

Pharma Blockchain Conference 2019 – see you there!
February 14, 2019

One of the most talked about technologies of 2018 is Blockchain.

Read More
CTi Development reaches key milestone
September 15, 2018

ClinTex are delighted to announce that the CTi Platform has reached a key development milestone this month.

Read More
Top 5 Blockchain Use Cases in Pharma and Healthcare – Clintex CTi will deliver Use Case 5
September 3, 2018

The blockchain technology is well suited for use cases involving track-and-trace, product provenance and supply chain governance.

Read More
Leveraging Blockchain for Clinical Trials/Research
March 23, 2018

Groundbreaking Technology Key for Improving Clinical Studies, Unlocking and Securing Data and Enhancing Patient Safety and Engagement

Read More
Cognoa’s AI platform for autism diagnosis gets first FDA stamp
March 20, 2018

Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism — meaning the digital health startup is now positioned to submit an application for full FDA clearance.

Read More
Pharma the next industry to embrace blockchain?
March 15, 2018

The mainstream press headlines are full these days of the tales of possibilities offered by blockchain technology.

Read More
Big Pharma Seeks DLT Solution for Drug Costs
March 12, 2018

What if blockchain could be used to actually save lives?

Read More
Roche To Buy Big Data Upstart Flatiron Health For $1.9 Billion
March 8, 2018

Roche, the Swiss drug giant, will buy New York-based Flatiron Health, which has become a leader in applying big data approaches to medicine, for $1.9 billion.

Read More
Regulatory Recognition – Cognoa
March 8, 2018

Cognoa has gained regulatory recognition for its machine learning software as a class II diagnostic medical device for autism

Read More
Streamline & Innovate Clinical Trials Operations Against A Backdrop of Shifting Priorities and Political Change
March 6, 2018

The 5th Annual Outsourcing in Clinical Trials UK & Ireland 2018 conference is back after a successful 2017 to help build business strategy through the changing regulatory and political climate.

Read More